Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Urology|April 19, 2005
Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinomaJill M Seargent, Paul M Loadman, Sandie W Martin, et al.
Journal of Pharmacological and Toxicological Methods|May 17, 2011
Use of the hollow fiber assay for the evaluation of DNA damaging agentsJ Pedro Veiga, Patricia A Cooper, Klaus Pors, et al.
Cancer Chemotherapy and Pharmacology|June 26, 2013
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rateRuth Duncan, Yee-Nee Sat-Klopsch, Angelika M Burger, et al.
Molecular Cancer Therapeutics|January 7, 2005
In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazolesChee Onn Leong, Marie Suggitt, David J Swaine, et al.
European Journal of Medicinal Chemistry|February 7, 2006
Polar, functionalized guanine-O6 derivatives resistant to repair by O6-alkylguanine-DNA alkyltransferase: implications for the design of DNA-modifying drugsDimitrios Pletsas, Richard T Wheelhouse, Vassiliki Pletsa, et al.
Journal of Natural Products|September 25, 2004
In-vitro cytotoxic activities of the major bromophenols of the red alga Polysiphonia lanosa and some novel synthetic isomersNagwa A Shoeib, Michael C Bibby, Gerald Blunden, et al.
Molecular Cancer Therapeutics|November 16, 2004
Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipidsSimon S Jensen, Thomas L Andresen, Jesper Davidsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Differentiation and definition of vascular-targeted therapiesDietmar W Siemann, Michael C Bibby, Graham G Dark, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomasJason H Gill, Ian G Kirwan, Jill M Seargent, et al.
Journal of Natural Products|October 29, 2005
Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1)George R Pettit, Mathew D Minardi, Heidi J Rosenberg, et al.
Pageof 3